Since Leqembi is dosed based on a patient’s weight and offered in single-use vials, about 5.8% of the drug dispensed will be ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions ...
New research suggests that Medicare could save up to 74 percent of the money lost from discarded Alzheimer's drug Leqembi or ...
Women and men experience similar rates of dangerous complications after a major heart surgery. So why are women dying at ...
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
Lecanemab (Leqembi; Eisai/Biogen) received traditional approval from the FDA in July 2023, following an accelerated approval ...
A recent study supported by the National Institutes of Health (NIH) and published in Nature Neuroscience found that Alzheimer ...
The Indian start-up ecosystem stands at a crossroads – while businesses may be bustling, the mental health of employees – on ...
Enrollment in a 2025 Medicare plan opened for beneficiaries today. News outlets focus on an array of changes that could lead to "benefit disruption" that consumers should know about, in particular ...
Leqembi (lecanemab) was cleared for marketing ... time – the two companies have a 50:50 profit-sharing arrangement. Medicare announced shortly after the approval that it would provide the ...
The green light for Leqembi (lecanemab ... a registry of treated patients was imposed in the US as a condition of Medicare reimbursement. The second regulatory approval is another boost to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback